Impact of statins on the survival of patients with cancer: a nationwide population-based cohort study in South Korea

作     者：Juhee Ahn Sungho Won Sanghun Lee 

作者机构：Department of Public Health ScienceSeoul National UniversityGwanak-guSeoul 08826Republic of Korea Interdisciplinary Program of BioinformaticsSeoul National UniversityGwanak-guSeoul 08826Republic of Korea Institute of Health and EnvironmentSeoul National UniversityGwanak-guSeoul 08826Republic of Korea Department of Bioconvergence&EngineeringDankook UniversityYongin-siGyeonggi-do 16890Republic of Korea Channing Division of Network MedicineBrigham and Women’s HospitalBostonMassachusetts 02115the United States of America 

出 版 物：《Cancer Communications》 (癌症通讯（英文）)

年 卷 期：2022年第42卷第2期

页      面：184-187页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：supported by a grant of the KoreaHealth Technology R&D Project through the Korea Health Indus-try Development Institute(KHIDI) funded by the Min-istry of Health&Welfare Republic of Korea(grant num-ber:HF20C0172) 

主　　题：cancer clinical drugs 

摘      要：Dear Editor For over 30 years,3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA)reductase inhibitors,statins,have been recommended worldwide as cost-effective lipid-lowering drugs for cardiovascular disease[1].Cheng et *** that lipid synthesis inhibitors are a promising anti-cancer treatment in preclinical studies and early phases of clinical trials[2].However,the association between statin use and cancer incidence or survival remains controversial[3,4].